glp-1 receptor agonist use and risk of suicide death Exploring the Side Effects Agonist: To Ensure Its Optimal Positioning JAMA - Most viewed in

A number of digital health companies including Ro, Noom, 23andMe and WeightWatchers also offer access to compounded GLP-1 medications

The results from the SUSTAIN 6 trial indicated that patients treated with semaglutide experienced a significantly higher incidence of DR compared to those receiving placebo (86)

Telemedicine With GLP-1 Behavior Program Shows Significant Declines in Weight, Blood Pressure | ADA 2025

Absorption considerations often relate to bypassing the digestive system, which some consumers view as a potential tolerability advantage compared with oral supplements, though individual responses can vary

Nevertheless, high levels of ketone bodies have been associated with an increased mortality risk (68)